FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Teva's metoclopramide product, updating its regulatory status as a marketed generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Gastroesophageal Reflux Disease
• Gastroparesis
• Postoperative Nausea and Vomiting

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE)